Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.181.491.371.031.28

What is the latest Working Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Working Capital/Sales ratio of BLISS GVS PHARMA is 1.18 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.18
Mar20231.49
Mar20221.37
Mar20211.03
Mar20201.28

How is Working Capital/Sales of BLISS GVS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.18
-20.81
Mar2023 1.49
8.76
Mar2022 1.37
33.01
Mar2021 1.03
-19.53
Mar2020 1.28 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Working Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,254.3 Cr -5.8% -1.7% 5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,126.0 Cr 1.4% 4.1% 18.7% Stock Analytics
DIVIS LABORATORIES ₹161,568.0 Cr -2.1% 4.2% 59.1% Stock Analytics
CIPLA ₹125,156.0 Cr -0.1% 5% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,176.0 Cr -0.3% 3% 23.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,716.1 Cr -1.5% 1.7% -5.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-5.8%

-1.7%

5.1%

SENSEX

0.2%

2.9%

8.7%


You may also like the below Video Courses